Table 1.
Subject Characteristics for PLA and AX groups (mean ± SD).
| PLA | AX | |||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| VO2 Peak (ml·kg−1·min−1) | 26.7 ± 7.0 | 26.6 ± 7.6 | 25.6 ± 6.3 | 24.1 ± 6.4 |
| Age (y) | 25.6 ± 4.2 | 30.2 ± 7.3 | ||
| Height (cm) | 169.1 ± 8.4 | 170.8 ± 9.6 | ||
| Mass (kg) | 94.1 ± 20.9 | 94.7 ± 20.6 | 96.2 ± 17.6 | 96.6 ± 17.5 |
| BMI (kg/m2) | 32.7 ± 5.3 | 32.9 ± 5.3 | 33.2 ± 5.5 | 33.4 ± 5.6 |
| BF % | 38.3 ± 8.3 | 38.6 ± 3.7 | 38.0 ± 6.9 | 38.2 ± 7.4 |
| Systolic BP (mm Hg) | 118 ± 12 | 124 ± 12 | 122 ± 10 | 126 ± 10 |
| Diastolic BP (mm Hg) | 82 ± 10 | 74 ± 8 | 82 ± 8 | 84 ± 10 |
PLA = placebo treatment; AX = astaxanthin treatment; BF% = bodyfat %; BP = blood pressure; BMI = body mass index.